Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia

MDS Study Group Mild Cognitive Impairment in Parkinson's Disease

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background: The criteria for PD-MCI allow the use of global cognitive tests. Their predictive value for conversion from PD-MCI to PDD, especially compared to comprehensive neuropsychological assessment, is unknown. Methods: The MDS PD-MCI Study Group combined four datasets containing global cognitive tests as well as a comprehensive neuropsychological assessment to define PD-MCI (n = 467). Risk for developing PDD was examined using a Cox model. Global cognitive tests were compared to neuropsychological test batteries (Level I&II) in determining risk for PDD. Results: PD-MCI based on a global cognitive test (MMSE or MoCA) increases the hazard for developing PDD (respectively HR = 2.57, P = 0.001; HR = 4.14, P = <0.001). The C-statistics for MMSE (0.72) and MoCA (0.70) were lower than those based on neuropsychological tests (Level I = 0.82; Level II = 0.81). Sensitivity, specificity and diagnostic accuracy balance was best in Level II. Conclusion: MMSE and MoCA predict conversion to PDD. However, Level II neuropsychological assessment seems the preferred assessment for PD-MCI.

Original languageEnglish
Pages (from-to)479-483
Number of pages5
JournalMovement Disorders Clinical Practice
Volume9
Issue number4
DOIs
Publication statusPublished - 1 May 2022

Keywords

  • Parkinson's disease
  • dementia
  • diagnostic accuracy
  • global cognitive tests
  • mild cognitive impairment

Cite this